Our Team
Dr. Stacy Blain
Co-founder, Chief Scientific Officer and acting CEO has over 20 years of experience in cell cycle biology and cancer research.
Jason Mraz
Co-founder and Business Advisor has over 20 years of investment management and start-up financing expertise.
Dr. Dominique Bridon
Chief Development Officer has over 30 years of C-suite executive and scientific leadership.
LisaMarie Casey
Co-founder and Chief Operating Officer has over 25 years of business development and start-up operating expertise.
Dr. Grace Chen
Research Scientist has over 8 years of experience in immunology and cell signaling research.
Scientific Advisors
Keren Paz, PhD
CSO, Stelexis Therapeutics
Gary Schwartz, MD
Division Chief Hem/Onc, Columbia University Medical Center
Neil Rosen, MD, PhD
Molecular Pharmacology and Chemistry Program, MSKCC
Andrew Koff, PhD
Molecular Biology Program, MSKCC
Geoffrey Shapiro, MD, PhD
Director, Early Drug Development Center
Dana-Farber Medical Center
Daniel Heller, PhD
Nanomedicine, MSKCC